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Summary: Plastic and reconstructive surgery has an illustrious history of
innovation. The advancement, if not the survival, of the specialty depends
on the continual development and improvement of procedures, practices,
and technologies. It follows that the safe adoption of innovation into clinical practice is also paramount. Traditionally, adoption has relied on the diffusion of new knowledge, which is a consistent but slow and passive process.
The emerging field of dissemination and implementation science promises
to expedite the spread and adoption of evidence-based interventions into
clinical practice. The field is increasingly recognized as an important function of academia and is a growing priority for major health-related funding institutions. The authors discuss the contemporary challenges of the
safe implementation and dissemination of new innovations in plastic and
reconstructive surgery, and call on their colleagues to engage in this growing field of dissemination and implementation science. (Plast. Reconstr.
Surg. 147: 304e, 2021.)

P

lastic and reconstructive surgery is characterized by its emphases on problem-solving,
rich diversity of procedures, and collaborative role with several surgical specialties. Proficient
in not only a singular anatomical system, the specialty fosters creativity, entrepreneurship, and a
degree of surgeon autonomy.1–4 Indeed, innovation has played a defining role in plastic and
reconstructive surgery since its origins. Harold
Gillies used staged reconstruction to restore the
faces of veterans during World War I.5,6 Joseph
Murray won a Nobel Prize for completing the
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first successful human kidney transplant.6,7 The
first microvascular anastomosis using an operating microscope was performed in 1960,8 soon followed by the first arm replantation in 1964.9 Of
the 50 most cited plastic and reconstructive surgery articles, nearly half introduced or modified a
surgical technique.10 It follows that continual and
widespread adoption of innovations is necessary
for the advancement and survival of the specialty.
Although research is considered a prerequisite for driving innovation,11 the process from
ideation to implementation typically takes many
decades.12 Our goals herein are three-fold: (1)
to call attention to contemporary challenges for
safe and ethical innovation in plastic and reconstructive surgery, (2) to discuss how the emerging field of dissemination and implementation
science (D&I) can help to speed the spread and
adoption of new ideas into clinical practice, and
(3) to identify next steps toward incorporating D&I science into plastic and reconstructive
surgery.
Disclosure: The authors have no financial disclosures to report in relation to this project. No funding
was used for the completion of this study.
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EXISTING STRATEGIES TO PROMOTE
INNOVATION IN PLASTIC AND
RECONSTRUCTIVE SURGERY
Despite the ubiquity of the term, there is no
consensus over what constitutes surgical innovation. Here, we define surgical innovation as (1)
the introduction of an entirely new procedure or
technology/product used for a procedure, (2)
the development of a substantial modification to
an existing procedure or technology/product for
a procedure, or (3) the application of an existing
procedure/technology/product to a new anatomical site or a new patient population.11,13
Implicit in this definition is some uncertainty
regarding the procedure’s risks and/or benefits
over other available treatments, and innovation
does not necessarily imply improvement. Indeed,
ethical innovation in any surgical discipline
demands robust evaluation of safety, efficacy, and
effectiveness.14,15 The decision to offer an innovative
procedure should depend on the patient’s goals
and expectations, the surgeon’s experiences and
incentives, the operative risks and available alternatives, and impact on society. In effect, this decision
should be difficult, and may often require expertise beyond an individual surgeon’s training. These
considerations are often particularly complex in
plastic and reconstructive surgery, as both aesthetic
and reconstructive surgeons routinely work with
vulnerable patient populations. Adequate oversight of safe innovation in plastic and reconstructive surgery remains an unmet need.
In recent years, multiple studies and societal
groups have proposed strategies to promote the
ethical development and application of surgical
innovations.10,14,16–20 In general, these strategies can
be categorized as either surgeon-level or systemslevel processes. Surgeon-level processes involve
strategies to facilitate shared decision-making and
informed consent, provide additional technical
training, and improve education on surgical ethics.
Proposed systems-level processes include oversight
by ethics and/or specialized innovation committees, approval by institutional review boards, longitudinal evaluation by accreditation or regulatory
groups, changes in incentive structures, and adherence to reporting guidelines in peer-reviewed publications. The IDEAL framework, for example,
provides a five-stage pathway from preclinical studies to patient registries through which surgical procedures should be developed and assessed.16,17
Unfortunately, implementing these strategies
has proven difficult. A recent international survey
of plastic surgeons found that half did not consider institutional review board approval to be

of high importance for surgical innovation, and
respondents reported low familiarity with ethics
of surgical innovation.13 Despite repeated calls in
their support, oversight committees and regulatory bodies have not been widely implemented.10
Concerns have also been raised that such groups
may stifle innovation, which could jeopardize
rather than promote patient safety.18
In this context, it is unlikely that any strategy
will be effective or sustainable in isolation. For
realistic reform, an understanding of how innovations are spread and adopted, and how these processes may be improved, is needed.
Understanding How Innovations Are Spread
Thomas Kuhn described scientific development as “a succession of tradition-bound periods
that are punctuated by sudden breaks and paradigm shifts.”21 However, a necessary stage between
the development of an innovation and its eventual
adoption is the process by which the innovation is
spread. Everett Rogers proposed the diffusion of
innovation paradigm in 1962 as a universal, general process of social change (Fig. 1).22 Diffusion,
in this context, is the passive spread of an idea or
innovation over time to members of a social system
through existing channels. Diffusion of innovation seeks to describe why it routinely takes several
years for an innovation to gain widespread adoption, and why an innovation that is superior to
existing methods may actually never be adopted.
Rogers defined five types of adopters in his
paradigm, each with distinct roles in the diffusion
process and relations to the “circle of local peer
networks” (Fig. 1). Innovators are outside the peer
network, which frees them from constraints of a
local system and allows them to generate new ideas.
Early adopters, well respected within the local system, are the first to accept an innovation. They have
the resources and risk tolerance to try new ideas.
In health care, the early adopters are commonly
elected leaders or representatives of clinical groups.
Their status decreases the uncertainty of a new idea,
which allows it to spread to the early majority, who
tend to embrace innovation but seldom hold positions of leadership. If there are no early adopters to
communicate a new idea, endorse it, and decrease
its uncertainty, the innovation will be rejected and
fail to achieve widespread adoption.
It is also important that early adopters modify the innovation (often, this means simplifying
the innovation) to promote and teach the new
idea.22 Once adoption has reached a critical level
of 15 to 20 percent of members in the local system, the idea spreads rapidly to most of the rest of
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Fig. 1. Diffusion of innovation. The bell-shaped curve (black) describes the diffusion of innovation across the social groups of innovators, early adopters, early majority, late majority,
and laggards. The S-curve (blue) describes the percentage of adoption across these social
groups. The tipping point occurs when an idea reaches 15 to 20 percent of adoption in
the local system, essentially transitioning into the early majority, after which there is rapid
“unstoppable” adoption in the group. (Modified from Rogers EM. Diffusion of Innovations.
5th ed. New York: Simon & Schuster; 2003. Adaptations are themselves works protected
by copyright. So in order to publish this adaptation, authorization must be obtained both
from the owner of the copyright in the original work and from the owner of copyright in
the translation or adaptation.)

the system (i.e., “tipping point”), including to the
late majority and the laggards, who are suspicious
and/or resistant to change.22 This spontaneous,
passive process takes time. Indeed, the treatment and prevention of scurvy with vitamin C, for
example, took over two centuries to be accepted,
and the more efficient Dvorak keyboard never
replaced the less efficient QWERTY keyboard that
is still used today.12,22 Another analogy is the time
it takes in the rise (Roger’s diffusion of innovation) and then fall of a surgical technique, known
together as Scott’s parabola (Fig. 2).23

WHAT CONTROLS THE SPEED OF
DIFFUSION?
The speed of diffusion is governed by (1) characteristics of the adopters, (2) characteristics of

the innovation itself, and (3) contextual factors.24
Surgeon adopters may be wary of a new intervention if what he or she has been doing “works well
in his/her hands.” Studies on the neuroscience of
learning suggest that, as a species, we are hardwired
to resist change and innovation, and instead seek
safety in constancy and predictability.25 Moreover,
our emotions affect learning. In his book Descartes’
Error,26 Antonio Damasio describes how emotions
“create an enduring or nontransient memory,
unique in its intensity”27 that does not require the
usual repetition to ensure a memory is sustained.
A single patient, or a single surgical encounter, can be so powerful that it imprints an indelible learning moment. Innovation-specific factors
include its complexity (simple ideas spread more
quickly), trialability (or the ability to test it on a
small scale), and observability (whether its effects
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Fig. 2. Scott’s parabola. If the S-curve of adoption is extended to represent when an idea falls into disuse, the curve becomes what
is known in surgery as Scott’s parabola—the rise and fall of a surgical technique. Roger’s diffusion of innovation is considered the
first half of Scott’s parabola. (Modified from Scott JW. Scott’s parabola: The rise and fall of a surgical technique. BMJ 2001;323:1447.
Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained
both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.)

are easily apparent). Important contextual factors include an organization’s culture, leadership,
communication and incentive structure, history,
and current needs. For example, health care organizations that foster social exchanges between
innovators and early adopters, and between early
adopters and the early majority, will see faster diffusion than organizations that discourage it or are
simply indifferent.
The factors may explain differences in the
uptake of practices in plastic and reconstructive
surgery. For example, nerve transfer, now a standard technique for the management of peripheral
nerve injuries, has had poor adoption in the tetraplegic population despite its first successful application over 10 years ago.28 In contrast, the use of
allograft for the treatment of bony hand and wrist
defects had very rapid uptake, despite good evidence suggesting its inferiority to autograft.29

THE BEGINNINGS OF D&I SCIENCE
With the accelerated pace of scientific advancements, the gap between evidence-based medicine,
or the care that could be provided, and actual
clinical practice continues to widen.30 Indeed, it is
estimated that it takes 17 years for just 14 percent
of medical research to influence patient care.12
In the years since the introduction of the diffusion of innovations paradigm, focus has shifted
toward means of improving and operationalizing
the spread and adoption of ideas.31 Collectively,

these investigations constitute a new area of study,
D&I science.
The field of D&I science has been described
in multiple terms, including “research translation,”32 “knowledge translation,”33 “knowledge to
action,”34 “evidence-based policy and practice,”35
and “research implementation,” among others.
Although this inconsistency of terminology may
create confusion,32,36 each term emphasizes the
active, directed, and planned spread of knowledge. D&I science promises to speed the safe
translation of medical research knowledge into
widespread clinical practice by moving Scott’s
parabola to the left (Fig. 3), and to narrow the
quality gap in health care.37 The two interrelated
components of D&I research are dissemination
science, the study of how knowledge and interventions can best be actively communicated to
potential adopters, and implementation science,
the study of how an intervention is actually put
into practice.37
The field of D&I science has grown exponentially over the past decade. It is increasingly recognized as an important function of academia,
and is a growing priority for major health-related
funders, including the National Institutes of
Health.38 Several peer-reviewed journals have
devoted special issues or sections to the topic of
implementation of evidence-based practices.39–48
For example, the impact factor for the openaccess peer-reviewed journal Implementation Science,
dedicated entirely to D&I science research, rose
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Fig. 3. Implementation and deimplementation. The field of dissemination and implementation (blue) promises to speed the
adoption of innovation, essentially reducing the time for surgeons to adopt a new technique. This aims to truncate the timeline of Roger’s parabola for diffusion of innovation and the first half of Scott’s parabola with the rise of a surgical technique.
Deimplementation (green), a new subfield within dissemination and implementation science, studies the process of when innovation falls into disuse, promising its quick and safe exit, and thereby making room for the next innovation. This aims to truncate the
timeline of the second half of Scott’s parabola with the fall of a surgical technique. OR, operating room.

quickly from 2.93 after its first year of publication
in 2006 to 5.65 by 2014. The uptake of D&I science in surgery, however, has been comparatively
slow. In fact, it could be said that early adopters of
D&I research, specifically in the surgical specialties, have yet to be identified.

A D&I APPROACH TO INNOVATION
IN PLASTIC AND RECONSTRUCTIVE
SURGERY
A D&I science approach involves (1) an evidence-based intervention (the issue of what constitutes evidence-based practices in plastic and
reconstructive surgery is addressed below; see

Contemporary Challenges in D&I Science) to be
scaled-up or introduced to a new patient population; (2) planned strategies to promote the dissemination, implementation, and sustainability
of the intervention; and (3) validated approaches
to evaluate whether the strategies were effective.49
Rather than relying on intuition or trial-and-error,
D&I uses validated models, often referred to as
frameworks or theories, to achieve these aims.
Popular models used in D&I research include
the Consolidated Framework for Implementation
Research, knowledge-to-action, promoting action
on research implementation in health services,
RE-AIM, and translation research continuum or
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T models.32 Choice of model depends on the purpose of the D&I study and on investigator preference. For example, RE-AIM was created as a
five-step framework (reach, efficacy, adoption,
implementation, and maintenance) to conceptualize the public health impact of an intervention.50
Whereas RE-AIM outlines criteria for the successful
implementation of an intervention, the T models
depict a general pathway in medical research from
ideation to implementation.51 The steps in this
pathway include T0 (description and discovery),52
T1 (basic science to clinical research), T2 (clinical
research to clinical practice),38 T3 (clinical practice
to large-scale dissemination),49 and T4 (large-scale
dissemination to population health outcomes).53
Irrespective of the selected model, the foundation of any D&I project is an understanding of
context. An understanding of context can help to
explain why surgical innovations are taken up in
some areas but not in others, such as geographic
variation in endoscopic versus open carpal tunnel release,54 or the use of custom computerassisted design and manufactured implants in
North America but less so in resource-restricted
countries. The Consolidated Framework for
Implementation Research model recommends
examining the inner setting, outer setting, and
characteristics of individuals for contextual
assessment.51 The inner setting may involve an
understanding of a hospital’s resources; an organization’s culture to accept or prioritize change;
or the relationships between physicians, patients,
and hospital administrators. The outer setting may
refer to how a plastic and reconstructive surgery
department interacts with the greater surgical,
regulatory, or patient community. Assessing the
outer setting may, for example, involve describing
what external financial incentives or disincentives
influence surgeons’ behaviors. Lastly, characteristics of individuals may refer to how surgeons view
their own responsibility to follow ethical practices and what they consider to be ethical practice. These constructs may be evaluated through
interviews, surveys, or consensus conferences,
but they remain poorly described in plastic and
reconstructive surgery. An understanding of context can help to explain why surgical innovations
are taken up in some geographic areas but not in
others.
The next step in a D&I study is to formulate
strategies to address barriers identified during
contextual assessment. Several validated strategies
have been developed to overcome common implementation barriers.49 As described by Proctor et
al.,49 a D&I project should use multiple strategies

to facilitate change at multiple levels, including
the systems and individual levels. Many previously
suggested methods for promoting ethical innovation, such as ethics training for surgeons or
oversight committees, are potential implementation strategies. Choice of strategy depends on the
purpose of the study and on the contextual assessment. After all, an oversight committee instituted
at a hospital with little funding or surgeon interest
would be unlikely to achieve its intended purpose.
The last component of a D&I study is to assess
whether its implementation strategies are successful. Commonly evaluated outcomes are acceptability, adoption, feasibility, fidelity, and sustainability
(Table 1).49,55,56 An important distinction between
traditional D&I research and clinical research is
that success is defined by how well the intervention
is disseminated or implemented rather than by
improvements in clinical outcomes57,58 (or “effectiveness research”59). The traditional assumption for D&I research is that the evidence-based
intervention will work as published, provided
that it is appropriately implemented. However,
this assumption is not always realistic, particularly
when the evidence for an intervention is relatively
modest or when the intervention’s generalizability has not yet been established. Hybrid designs
have been developed that combine D&I and effectiveness research; they are defined by how much
emphasis is placed on testing the implementation
strategies versus gathering clinical information on
the intervention.58

DEIMPLEMENTATION OF HARMFUL OR
INEFFECTIVE INTERVENTIONS
In addition to promoting the uptake of evidence-based interventions, there is also a need
to replace or abandon existing interventions
that are harmful or ineffective. This process of
deimplementation (the right half of Scott’s parabola) (Fig. 3) has intuitive implications for surgical innovation, and it is a fledgling area of study
within D&I science.60 Speeding the discontinuation of less effective alternatives makes room for
new innovations and interventions, and deimplementation may also help curtail the inappropriate spread of new yet harmful practices. The
development of distal nerve transfers for proximal nerve injuries highlights the importance of
deimplementation in the innovation process.
Traditionally, these injuries have been managed
with nerve grafting. However, the introduction of
nerve transfer surgery takes advantage of nearby
expendable nerves to convert a more proximal
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Table 1. Common Implementation Outcomes and Definitions Proposed by Proctor et al.*
Outcome
Acceptability
Adoption
Feasibility

Fidelity
Sustainability

Definition

Example Measure

How agreeable an innovation or set of implementation strategies is to stakeholders
The uptake of an innovation among stakeholders
The degree to which an innovation can be used in actual
practice; it is distinct from acceptability, in that an innovation may be agreeable but impractical for a setting because
of resource or training limitations
Adherence to the implementation protocol; it describes the
match between how an innovation was meant to be implemented and how it was actually implemented
The degree to which an innovation or a set of implementation strategies is maintained over time; it reflects the stable
integration of the practice within an organization

EBPAS†
Survey assessing the fraction of surgeons
who have offered the innovative procedure
when indicated
Semistructured interviews with surgeons
and/or hospital administrators
SDM-Q-9 questionnaire‡
A follow-up survey assessing long-term fidelity and adoption

EBPAS, Evidence-Based Practice Attitude Scale; SDM-Q-9, nine-item Shared Decision-Making Questionnaire.
*Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: Conceptual distinctions, measurement challenges, and
research agenda. Adm Policy Ment Health 2011;38:65–76.
†Aarons GA. Mental health provider attitudes toward adoption of evidence-based practice: The Evidence-Based Practice Attitude Scale
(EBPAS). Ment Health Serv Res. 2004;6:61–74.
‡Kriston L, Scholl I, Hölzel L, Simon D, Loh A, Härter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9): Development and
psychometric properties in a primary care sample. Patient Educ Couns. 2010;80:94–99.

injury to a distal injury, thereby shortening reinnervation time and leading to superior functional outcomes.61,62 Unfortunately, even nerve
repair with tension and joint flexion are still used
to repair nerve gaps by some surgeons. Other
examples in plastic and reconstructive surgery
include the deimplementation of Allergan Biocell
(Allergan Medical Corporation, Santa Barbara,
Calif.) textured breast implants63,64 and titanium
mesh cranioplasties.65,66 D&I models to guide
deimplementation efforts are active areas of study.
Of course, not all innovations undergo deimplementation. Some innovations ride the crest of
adoption for a very long time before an improvement or new innovation replaces the existing
innovation (Fig. 4). The goal of D&I science is to
retain adoption until a new innovation becomes
the standard of care.

CONTEMPORARY CHALLENGES IN
D&I SCIENCE
Although the goal of D&I science is to promote
implementation of an evidence-based intervention,
the amount and level of evidence required before
an innovation is considered ready for dissemination in surgery remains an unanswered question.67
Indeed, the majority of published studies in plastic
and reconstructive surgery journals offer relatively
low-quality evidence.68–70 As such, hybrid designs,58
which gather clinical information while also testing
implementation strategies, rather than traditional
D&I studies may be most applicable in plastic and
reconstructive surgery (Fig. 5).

Furthermore, because of restrictive inclusion
criteria, high-level evidence from randomized trials is often not directly applicable to the majority of patients seen in everyday clinical practice.
Recently, practice-based research networks have
been developed to better understand issues arising in daily practice and the gap between recommended and actual care.71 Academic institutions
may play an important role in collaborating with
community clinicians through practice-based
research networks to encourage the uptake of new
interventions and practices; this includes those in
private and hybrid practices.
Finally, the use of new media and emerging
technologies also accelerates the rate at which
information is disseminated.72 They allow for the
creation of large, online communities37 and have
been shown to expand reach in health promotion,73 disease prevention,74 telehealth,75,76 and
cybermedicine.77 However, these modalities may
also lead to the spreading of misinformation, as
exemplified by the rise in the modern antivaccine
campaign.78 The safe and ethical use of media and
technology to disseminate new information is a
necessary but unmet need.

A CALL TO ACTION
Ensuring the widespread adoption of necessary practices in plastic and reconstructive surgery
requires a realignment of academic and financial incentives. Although considerable emphasis,
time, and funding is placed on developing innovations, there is comparatively little focus on sharing
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Fig. 4. Sustainability of an innovation. Adoption of a new innovation (innovation #2) necessarily leads to deimplementation of an
existing innovation (innovation #1). The goal of dissemination and implementation science is to retain adoption until a new innovation becomes the standard of care, termed “sustainability.”

Fig. 5. Translating an innovation from idea to society. The fields of basic science, translational science, clinical research, knowledge
translation, implementation science, and policy change all play an important role in bringing an innovation from idea to society.
Plotted over time, these fields overlap and occur concurrently. Hybrid designs (Glasgow RE, Vogt TM, Boles SM. Evaluating the
public health impact of health promotion interventions: The RE-AIM framework. Am J Public Health 1999;89:1322–1327), which
gather clinical information (levels V through I evidence) while also testing implementation strategies, rather than traditional dissemination and implementation science studies, may be most applicable in plastic and reconstructive surgery. (Modified from
2018 Translational Research Program, University of Toronto. Adaptations are themselves works protected by copyright. So in order
to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the
owner of copyright in the translation or adaptation.)

innovations once developed. In the present system,
an innovating surgeon may be rewarded for developing and hoarding a new intervention, becoming the expert on that procedure and collecting
referrals. However, establishing a culture and

system to facilitate the sharing of ideas is essential
for advancement of plastic and reconstructive surgery, and demands new perspectives in health care
policy, health care delivery, and reimbursement.79
The current business model of reimbursing for
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high–relative value unit procedures in many academic departments stifles both scholarship and
innovation, and D&I science emphasizes collaboration over competition. This cultural shift will
require input from all stakeholders, including
the plastic surgery community-at-large, governing organizations, policy makers, even patients
themselves. The role that each of these stakeholders will play remains to be determined. A potential starting point could be increased funding
by plastic and reconstructive surgery organizations (e.g., Plastic Surgery Foundation, American
Association of Plastic Surgeons) for CME activities and research in D&I science. This could be
a single strategy in a multifaceted plan to bring
about larger, systemic change. Although these
issues are shared across surgical disciplines, plastic surgeons are perhaps uniquely situated to lead
such reforms, given the fundamental importance
of innovation to the specialty.
The emerging field of D&I science provides
strategies to study and facilitate the safe spread
and adoption of surgical innovations. It is imperative that, as a group, we become involved in
this growing field, and address the contemporary issues facing our specialty. These next steps
include the following:
• Defining evidence in plastic and reconstructive surgery: what level of evidence is
required to disseminate a new innovation?
• Advocating for culture change and financial
support to foster the spread of innovations.
• Applying D&I models to new innovations to
ensure their adoption.
• Actively deimplementing harmful or ineffective interventions.
• Using media responsibly to spread innovation.
• Developing and participating in practicebased research networks.
• Developing and maintaining an awareness
of our own personal resistance to change.
• Engaging with meetings and journals that
focus on D&I science.
Through such efforts, we will continue to
accelerate improvements in the safety and quality of surgical care in plastic and reconstructive
surgery.
Susan E. Mackinnon, M.D.
Division of Plastic and Reconstructive Surgery
Washington University in St. Louis
660 South Euclid Avenue, Campus Box 8238
St. Louis, Mo. 63110
mackinnons@wustl.edu
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